| 产品详情 |
| Edit |   |
|---|
| Product Name | NSC-23925 |
|---|
| Description | NSC-23925 is a potent plasma membrane glycoprotein 1(Pgp1) inhibitor. It inhibits Pgp1 and reverses MDR1 (Pgp1) but does not inhibit MRP or BCRP-mediated MDR. NSC23925 directly inhibits the function of Pgp1 in a dose-dependent manner without altering the total expression level of Pgp1. NSC23925 stimulates ATPase activity of Pgp. MW: 421.36. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 2-(p-Methoxyphenyl)-α-2-piperidyl-4-quinolinemethanol dihydrochloride, NSC-23925, [2-(4-Methoxyphenyl)4-quinolinyl]-(piperidin-2-y)-methanol dihydrochloride |
|---|
| Gene, Accession, CAS # | CAS: 858474-14-3 |
|---|
| Catalog # | 2686-25 |
|---|
| Price | |
|---|
| Order / More Info | NSC-23925 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|